BioCentury
ARTICLE | Clinical News

BioCryst preclinical data

October 10, 2016 7:00 AM UTC

In rhesus macaques infected with Ebola virus, twice-daily 100 mg/kg intramuscular BCX4430 starting 2 days post-inoculation followed by twice-daily 25 mg/kg BCX4430 for an additional 9 days led to a 10...